computerassist
tool
drug
design
discoveri
incred
modern
comput
resourc
much
appreci
throughout
world
ligandand
structurebas
approach
increasingli
use
design
small
lead
druglik
molecul
anticip
multitarget
activ
variou
ligandbas
method
develop
effect
comprehens
applic
virtual
screen
vs
de
novo
design
lead
optim
pharmacophor
becom
one
major
ligandbas
tool
comput
chemistri
drug
research
develop
process
molecular
recognit
includ
acid
acid
interact
play
signific
role
mani
biolog
respons
consequ
identif
bind
mode
affin
drug
molecul
crucial
understand
underli
mechan
action
respect
therapeut
respons
perspect
structurebas
drug
design
alway
frontrunn
among
avail
drug
design
approach
molecular
dock
one
larg
acclaim
structurebas
approach
wide
use
studi
molecular
recognit
aim
predict
bind
mode
bind
affin
complex
form
two
constitu
molecul
known
structur
hand
novel
techniqu
invent
last
decad
employ
combin
inform
comput
receptor
ligand
tool
defin
combin
structureand
ligandbas
design
tool
evolut
drug
discoveri
techniqu
undoubtedli
method
like
compar
bind
energi
analysi
combin
compar
residu
interact
analysi
coria
frontrunn
abovement
approach
encourag
success
applic
drug
discoveri
silico
screen
gener
defin
vs
use
ration
select
compound
biolog
vitroin
vivo
test
chemic
librari
databas
hundr
thousand
compound
vs
approach
use
comput
priorit
drug
candid
molecul
futur
synthesi
use
certain
filter
filter
may
creat
employ
knowledg
protein
target
structurebas
vs
known
bioactiv
ligand
ligandbas
vs
comput
method
power
tool
suppli
straightforward
way
estim
properti
molecul
establish
probabl
drug
candid
huge
number
compound
time
costeffect
way
combin
bioinformat
chemoinformat
crucial
success
vs
chemic
librari
altern
complementari
approach
highthroughput
screen
ht
lead
discoveri
process
simpli
state
vs
attempt
improv
probabl
identifi
bioactiv
molecul
maxim
true
posit
ratethat
rank
truli
activ
molecul
high
possibl
one
promis
silico
concept
computeraid
drug
design
cadd
pharmacophor
term
pharmacophor
first
coin
paul
ehrlich
earli
monti
kier
introduc
physic
chemic
concept
pharmacophor
seri
paper
publish
pharmacophor
techniqu
modern
drug
discoveri
extrem
use
interfac
medicin
chemistri
comput
chemistri
vs
librari
design
effici
hit
discoveri
well
optim
lead
compound
final
drug
candid
recent
research
focus
practic
parallel
screen
use
pharmacophor
model
bioactiv
profil
earlystag
risk
assess
probabl
advers
effect
toxic
due
interact
drug
candid
antitarget
hypothesi
pharmacophor
base
molecular
recognit
biolog
target
class
compound
explain
set
common
featur
interact
set
complementari
site
biolog
target
along
featur
threedimension
relationship
featur
anoth
crucial
compon
pharmacophor
concept
close
link
wide
use
principl
bioisoster
adopt
medicin
chemist
design
bioactiv
compound
seri
pharmacophor
simpli
defin
follow
state
intern
union
pure
appli
chemistri
iupac
definit
term
given
wermuth
et
al
pharmacophor
describ
essenti
steric
electron
functiondetermin
point
necessari
optim
interact
relev
pharmacolog
target
also
thought
templat
partial
descript
molecul
certain
blank
need
fill
type
ligand
molecul
size
divers
data
set
great
impact
result
pharmacophor
model
although
pharmacophor
model
signifi
key
interact
ligand
biolog
target
neither
structur
target
ident
requir
construct
handi
pharmacophor
model
consequ
pharmacophor
approach
often
consid
vital
access
inform
restrict
exampl
one
know
noth
structur
activ
ligand
pharmacophor
answer
simpl
hypothet
exampl
illustr
defin
common
pharmacophor
three
wellknown
compound
name
epinephrin
norepinephrin
isoprenalin
introduc
term
pharmacophor
year
ehrlich
nicknam
father
drug
discoveri
defin
molecular
framework
carri
phoro
essenti
featur
respons
drug
pharmacon
biolog
activ
although
first
definit
term
credit
ehrlich
kier
introduc
physic
chemic
concept
late
earli
describ
common
molecular
featur
ligand
import
central
nervou
system
receptor
label
muscarin
pharmacophor
kier
past
pharmacophor
model
mainli
work
manual
assist
use
simpl
interact
molecular
graphic
visual
program
later
grow
complex
molecular
structur
requir
refin
comput
program
determin
use
pharmacophor
model
evolut
comput
chemistri
fundament
percept
pharmacophor
model
simpl
geometr
depict
key
molecular
interact
remain
unchang
advanc
comput
chemistri
past
year
varieti
autom
tool
pharmacophor
model
applic
emerg
consider
number
studi
carri
sinc
develop
pharmacophor
approach
pharmacophor
approach
use
comprehens
vs
de
novo
design
well
lead
optim
multitarget
drug
design
conform
expans
critic
step
sinc
goal
repres
coverag
conform
space
molecul
also
either
bioactiv
conform
part
set
gener
conform
least
cluster
conform
close
enough
bioactiv
conform
conform
search
divid
four
categori
systemat
search
torsion
space
ii
cluster
want
need
iii
stochast
method
mont
carlo
mc
sampl
pole
iv
molecular
dynam
commonli
employ
conform
search
method
best
fast
conform
algorithm
base
energi
screen
recurs
buildup
caesar
gener
conform
provid
broad
coverag
access
conform
space
fast
conform
gener
method
search
conform
torsion
space
take
less
time
best
method
provid
complet
improv
coverag
conform
space
perform
rigor
energi
minim
optim
conform
torsion
cartesian
space
use
pole
algorithm
caesar
base
divideandconqu
recurs
conform
approach
approach
also
combin
case
local
rotat
symmetri
conform
duplic
due
topolog
symmetri
systemat
search
effici
elimin
next
step
threedimension
pharmacophor
gener
hypogen
hiphop
two
commonli
use
algorithm
predict
pharmacophor
gener
three
phase
construct
subtract
optim
phase
follow
construct
phase
hiphop
intend
deriv
common
featur
hypothesisbas
pharmacophor
model
use
inform
set
activ
compound
hiphop
requir
select
templat
rather
molecul
treat
templat
turn
differ
configur
chemic
featur
identifi
templat
molecul
use
prune
exhaust
search
start
small
set
featur
extend
larger
configur
found
next
configur
compar
remain
molecul
identifi
configur
common
molecul
result
pharmacophor
rank
use
combin
well
molecul
train
set
map
onto
pharmacophor
model
hiphop
user
defin
mani
molecul
must
map
complet
partial
pharmacophor
configur
hypogen
algorithm
use
activ
valu
small
compound
train
set
gener
hypothes
build
pharmacophor
model
hypogen
identifi
allow
pharmacophor
consist
five
featur
among
two
activ
compound
investig
remain
activ
compound
list
subtract
phase
phase
deal
pharmacophor
creat
construct
phase
remov
pharmacophor
data
structur
like
use
optim
phase
optim
phase
perform
use
simul
anneal
algorithm
maximum
hypothes
gener
run
hypogen
develop
model
differ
pharmacophor
featur
hydrogenbond
acceptor
hba
ii
hydrogenbond
donor
hbd
iii
hydrophob
hyd
hydrophob
aliphat
hydrophob
aromat
iv
neg
charg
neg
charg
v
neg
ioniz
ni
vi
posit
charg
po
charg
vii
posit
ioniz
pi
viii
ring
aromat
ra
hypothes
gener
analyz
term
correl
coeffici
cost
function
valu
basic
pharmacophor
featur
illustr
figur
pharmacophor
model
usual
label
base
number
featur
exampl
pharmacophor
model
consist
three
four
featur
term
threepoint
pharmacophor
fourpoint
pharmacophor
respect
simpl
graphic
represent
shown
figur
hypogen
modul
perform
fix
cost
calcul
repres
simpl
model
fit
data
null
cost
calcul
assum
relationship
data
set
experiment
activ
normal
distribut
averag
valu
small
rang
total
hypothesi
cost
obtain
hypothes
indic
homogen
correspond
hypothesi
train
set
select
purpos
pharmacophor
gener
adequ
valu
total
cost
close
fix
cost
indic
fact
hypothes
gener
statist
robust
total
cost
hypothesi
calcul
per
eq
e
w
c
coeffici
associ
error
e
weight
w
configur
c
compon
respect
two
import
cost
involv
fix
cost
null
cost
fix
cost
repres
simplest
model
perfectli
fit
data
calcul
eq
x
deviat
expect
valu
weight
error
null
cost
cost
pharmacophor
activ
data
everi
molecul
train
set
averag
valu
activ
set
pharmacophor
featur
therefor
contribut
weight
configur
compon
appli
null
cost
calcul
per
eq
null
cost
est
est
averag
scale
activ
train
set
molecul
suggest
differ
cost
gener
hypothesi
null
hypothesi
larg
possibl
valu
bit
differ
may
indic
chanc
repres
true
correl
data
set
use
total
cost
hypothesi
toward
valu
fix
cost
repres
meaning
model
two
import
output
paramet
configur
cost
error
cost
valu
configur
cost
higher
may
indic
correl
gener
pharmacophor
like
due
chanc
error
cost
increas
valu
root
mean
squar
rm
increas
rm
deviat
rmsd
repres
qualiti
correl
estim
actual
activ
data
pharmacophor
model
select
base
accept
correl
coeffici
r
cost
analysi
valid
three
subsequ
step
fischer
random
test
ii
test
set
predict
iii
gh
score
method
fischer
random
test
first
crossvalid
perform
statist
signific
correl
estim
random
data
use
fischer
random
test
done
scrambl
activ
data
train
set
molecul
assign
new
valu
follow
gener
pharmacophor
hypothes
use
featur
paramet
use
develop
origin
pharmacophor
hypothesi
origin
hypothesi
consid
gener
mere
chanc
random
data
set
result
gener
pharmacophor
better
nearli
equal
correl
compar
origin
one
test
set
predict
purpos
pharmacophor
hypothesi
gener
predict
activ
train
set
compound
also
predict
activ
extern
molecul
object
verifi
whether
pharmacophor
abl
predict
activ
test
set
molecul
agreement
experiment
determin
valu
activ
test
set
molecul
estim
base
map
test
set
molecul
develop
pharmacophor
model
conform
gener
test
set
molecul
base
method
use
conform
gener
train
set
map
use
correspond
pharmacophor
model
thu
predict
capac
model
judg
base
predict
r
valu
r
pred
threshold
valu
classificationbas
method
sensit
specif
precis
accuraci
test
set
cover
similar
structur
divers
train
set
order
establish
broad
pharmacophor
predict
gh
score
gh
score
method
employ
follow
test
set
valid
evalu
qualiti
pharmacophor
model
gh
score
success
appli
quantifi
model
select
precis
hit
recal
activ
directori
use
decoy
dud
data
set
consist
known
activ
inact
dud
publicli
avail
databas
free
use
gener
base
observ
physic
characterist
decoy
background
use
classif
differ
compound
dud
download
http
duddockingorg
method
involv
evalu
follow
percent
yield
activ
databas
recal
percent
ratio
activ
hit
list
precis
enrich
factor
e
gh
score
gh
score
rang
valu
signifi
ideal
model
follow
metric
use
analyz
hit
list
pharmacophor
databas
search
equat
percentag
known
activ
compound
retriev
databas
precis
ha
number
activ
hit
list
true
posit
number
activ
compound
databas
percentag
known
activ
hit
list
recal
ht
number
hit
retriev
number
compound
databas
e
enrich
concentr
activ
model
rel
random
screen
without
pharmacophor
approach
basic
step
pharmacophor
formal
repres
figur
pharmacophor
model
gener
two
way
first
method
ligandbas
model
set
activ
molecul
superimpos
common
chemic
featur
extract
necessari
bioactiv
second
structurebas
model
perform
probe
possibl
interact
point
macromolecular
target
ligand
ligandbas
pharmacophor
lbp
model
becom
import
comput
tool
assist
drug
discoveri
case
nonavail
macromolecular
target
structur
lbp
usual
carri
extract
common
chemic
featur
structur
known
set
ligand
repres
fundament
interact
ligand
specif
macromolecular
target
case
lbp
model
pharmacophor
gener
multipl
ligand
involv
two
major
step
first
creation
conform
space
ligand
train
set
repres
conform
flexibl
ligand
align
multipl
ligand
train
set
second
determin
essenti
common
chemic
featur
build
pharmacophor
model
conform
analysi
ligand
perform
molecular
align
key
techniqu
well
main
complex
lbp
model
challeng
still
exist
spite
great
advanc
lbp
model
first
problem
one
seriou
model
ligand
flexibl
present
two
strategi
util
deal
problem
first
preenumer
method
multipl
conform
ligand
precomput
save
databas
advantag
approach
lower
comput
cost
conduct
molecular
align
expens
possibl
need
mass
storag
capac
second
approach
onthefli
method
conform
analysi
carri
pharmacophor
model
process
approach
need
mass
storag
might
need
higher
central
process
unit
cpu
time
conduct
meticul
optim
demonstr
preenumer
method
outperform
onthefli
calcul
approach
recent
consider
number
advanc
algorithm
establish
sampl
conform
space
small
molecul
list
tabl
importantli
good
conform
gener
ensur
follow
condit
profici
gener
put
bound
conform
small
molecul
adopt
interact
macromolecul
ii
keep
list
lowenergi
conform
short
possibl
avoid
combin
explos
problem
iii
less
time
consum
conform
calcul
b
molecular
align
second
issu
concern
lbp
model
align
method
classifi
two
approach
term
elementari
natur
pointbas
propertybas
point
pointbas
method
discrimin
atom
fragment
chemic
featur
pointbas
algorithm
pair
atom
fragment
chemic
featur
point
usual
superimpos
employ
leastsquar
fit
major
disadvantag
approach
requir
predefin
anchor
point
gener
point
becom
problemat
case
differ
ligand
consequ
propertybas
algorithm
util
molecular
field
descriptor
gener
repres
set
gaussian
function
gener
align
recent
new
align
method
develop
includ
stochast
proxim
embed
atom
properti
field
fuzzi
pattern
recognit
gridbas
interact
energi
c
third
challeng
lie
appropri
select
train
set
compound
although
problem
simpl
nontechn
often
puzzl
research
nonetheless
type
ligand
molecul
size
data
set
chemic
divers
larg
affect
consider
final
gener
pharmacophor
model
structurebas
pharmacophor
sbp
model
directli
depend
structur
macromolecular
target
complex
number
experiment
determin
structur
target
grown
larg
number
sbp
method
attract
signific
interest
last
decad
approach
consid
complementari
one
dock
procedur
provid
level
inform
well
less
demand
respect
requir
comput
resourc
protocol
sbp
model
involv
analyz
complementari
chemic
featur
activ
site
spatial
relationship
develop
pharmacophor
model
assembl
select
featur
sbp
model
classifi
two
subclass
base
macromolecul
without
ligand
base
approach
suitabl
identifi
ligand
bind
site
macromolecular
target
determin
key
interact
point
ligand
target
protein
ligandscout
excel
softwar
program
incorpor
scheme
program
like
pocket
gbpm
base
approach
major
limit
process
requir
structur
complex
consequ
appli
case
ligand
target
bind
site
interest
known
solv
macromoleculebas
approach
sbp
method
implement
discoveri
studio
softwar
typic
exampl
macromoleculebas
approach
commonli
encount
difficulti
sbp
model
identif
mani
chemic
featur
specif
bind
site
macromolecular
target
pharmacophor
model
consist
mani
chemic
featur
eg
seven
appropri
practic
applic
eg
databas
screen
therefor
alway
import
pick
restrict
number
chemic
featur
usual
three
seven
creat
reliabl
pharmacophor
hypothesi
one
signific
drawback
obtain
pharmacophor
hypothesi
replic
quantit
relationship
qsar
model
gener
base
singl
complex
singl
macromolecul
enrich
pharmacophor
techniqu
last
two
decad
made
approach
one
signific
tool
drug
discoveri
spite
advanc
key
techniqu
pharmacophor
model
space
addit
improv
deriv
precis
best
possibl
pharmacophor
model
includ
better
handl
ligand
flexibl
profici
molecular
align
algorithm
precis
model
optim
along
pharmacophorebas
vs
de
novo
design
applic
pharmacophor
extend
lead
optim
multitarget
drug
design
activ
profil
target
identif
applic
pharmacophor
techniqu
demonstr
schemat
way
figur
pharmacophor
model
use
queri
chemic
databas
search
potenti
ligand
process
term
pharmacophorebas
vs
case
pharmacophorebas
vs
approach
pharmacophor
hypothesi
taken
templat
intent
behind
screen
actual
discov
hit
chemic
featur
similar
templat
sometim
hit
might
relat
known
activ
compound
complet
novel
scaffold
screen
process
involv
two
major
difficulti
handl
conform
flexibl
small
molecul
pharmacophor
pattern
identif
flexibl
small
molecul
handl
either
preenumer
multipl
conform
molecul
conform
sampl
search
time
pharmacophor
pattern
identif
usual
known
substructur
search
perform
check
whether
queri
pharmacophor
present
given
conform
molecul
commonli
use
approach
substructur
search
ullmann
backtrack
algorithm
gener
match
algorithm
gma
challeng
problem
pharmacophorebas
vs
percentag
virtual
hit
realli
bioactiv
simpler
word
screen
result
produc
higher
falseposit
rate
higher
falseneg
rate
mani
factor
like
qualiti
composit
pharmacophor
model
macromolecular
target
inform
contribut
problem
probabl
factor
follow
critic
one
develop
robust
reliabl
pharmacophor
hypothesi
address
issu
requir
inclus
valid
optim
pharmacophor
model
b
differ
molecul
retriev
vs
differ
hypothes
singl
pharmacophor
model
probabl
import
reason
higher
falsepositivefalseneg
rate
studi
c
flexibl
target
macromolecul
pharmacophor
approach
handl
introduc
toler
radiu
pharmacophor
featur
unlik
entir
account
macromolecular
flexibl
case
recent
attempt
integr
molecular
dynam
simul
md
pharmacophor
model
recommend
pharmacophor
model
gener
md
trajectori
explain
consider
enhanc
represent
flexibl
pharmacophor
steric
restrict
macromolecular
target
adequ
consid
pharmacophor
model
although
partial
account
consider
exclud
volum
case
interact
ligand
protein
distancesensit
particularli
shortrang
interact
electrostat
interact
pharmacophor
model
tricki
account
consequ
combin
pharmacophorebas
dockingbas
vs
consid
effici
approach
vs
anoth
vital
applic
pharmacophor
de
novo
design
ligand
case
pharmacophorebas
vs
obtain
compound
gener
exist
chemic
might
patent
protect
contrari
de
novo
design
approach
use
gener
entir
novel
candid
structur
match
requir
given
pharmacophor
first
pharmacophorebas
de
novo
design
program
newlead
use
set
disconnect
molecular
fragment
consist
pharmacophor
model
input
select
set
disconnect
pharmacophor
fragment
subsequ
connect
use
variou
linker
atom
chain
ring
moieti
limit
newlead
handl
case
pharmacophor
featur
function
group
typic
chemic
featur
addit
inadequaci
newlead
program
steric
illicit
region
bind
site
consid
result
compound
creat
newlead
program
might
tricki
chemic
synthes
program
like
ludi
builder
also
use
amalgam
identif
sbp
de
novo
design
program
requir
knowledg
structur
macromolecular
target
recent
program
call
phdd
pharmacophorebas
de
novo
design
method
druglik
molecul
design
huang
et
al
overcom
limit
present
pharmacophorebas
de
novo
design
softwar
tool
phdd
involuntarili
creat
druglik
compound
satisfi
necess
input
pharmacophor
hypothesi
pharmacophor
use
phdd
consist
set
abstract
chemic
featur
exclud
volum
steric
forbidden
region
bind
site
case
phdd
first
gener
set
new
molecul
entir
conform
requir
given
pharmacophor
model
thereaft
seri
evalu
gener
molecul
carri
includ
assess
druglik
bioactiv
synthet
conveni
like
approach
pharmacophor
advantag
disadvantag
major
advantag
limit
follow
advantag
pharmacophor
model
use
vs
larg
databas
need
know
bind
site
ligand
macromolecular
target
protein
although
true
lbp
model
use
design
optim
drug
scaffold
hop
conceptu
obtain
even
structur
represent
approach
comprehens
edit
ad
omit
chemic
featur
constraint
inform
easili
trace
sourc
limit
pharmacophor
faster
less
accur
pharmacophor
pharmacophor
base
ligand
structur
conform
interact
protein
integr
interest
point
case
sbp
model
use
solv
problem
sensit
physicochem
featur
pharmacophor
model
extens
use
immens
access
commerci
softwar
packag
also
freeli
avail
web
server
call
pharmagist
http
detect
pharmacophor
group
ligand
known
bind
particular
target
complet
list
differ
commerci
freeli
avail
softwar
program
modul
use
pharmacophor
model
given
tabl
molecular
dock
studi
two
molecular
structur
eg
drug
enzym
protein
fit
togeth
simpl
definit
dock
molecular
model
techniqu
use
predict
protein
enzym
interact
small
molecul
ligand
abil
protein
enzym
nucleic
acid
interact
small
molecul
form
supramolecular
complex
play
major
role
dynam
protein
may
enhanc
inhibit
biolog
function
behavior
small
molecul
bind
pocket
target
protein
describ
molecular
dock
method
aim
identifi
correct
pose
ligand
bind
pocket
protein
predict
affin
ligand
protein
base
type
ligand
dock
classifi
molecul
ligand
dock
acid
dock
dock
molecul
ligand
dock
repres
simpler
end
complex
spectrum
mani
avail
program
perform
particularli
well
predict
molecul
may
potenti
inhibit
protein
dock
typic
much
complex
reason
protein
flexibl
conform
space
quit
vast
dock
perform
place
rigid
molecul
fragment
protein
activ
site
use
differ
approach
like
cliquesearch
geometr
hash
pose
cluster
perform
dock
depend
search
algorithm
eg
mc
method
genet
algorithm
ga
fragmentbas
method
tabu
search
distanc
geometri
method
score
function
like
forc
field
ff
method
empir
free
energi
score
function
first
step
dock
gener
composit
possibl
conform
orient
protein
pair
ligand
second
step
score
function
take
input
return
number
indic
favor
interact
identifi
activ
site
protein
first
select
requir
xray
cocrystal
structur
protein
data
bank
pdb
perform
extract
bound
ligand
one
optim
protein
activ
site
interest
process
identif
activ
site
protein
critic
bound
ligand
absent
crystal
structur
case
one
follow
procedur
one
perform
comprehens
literatur
review
sourc
paper
xray
crystal
structur
includ
pdb
identifi
activ
site
residu
b
establish
drug
give
pharmacolog
action
interest
avail
protein
activ
site
drug
identifi
initi
phase
analysi
one
tri
residu
activ
bind
site
test
ligand
c
everi
dock
softwar
program
usual
particular
algorithm
identifi
activ
site
protein
allow
bind
ligand
differ
part
protein
explor
best
possibl
bind
posit
ligand
protein
understand
dock
studi
better
one
need
know
basic
term
relat
dock
studi
commonli
use
term
connect
dock
studi
defin
next
discuss
term
graphic
repres
figur
receptor
receptor
protein
molecul
polymer
structur
cell
distinct
recogn
bind
molecul
ligand
act
molecular
messeng
ligand
bind
receptor
caus
kind
cellular
respons
ligand
ligand
complementari
partner
molecul
bind
receptor
effect
bimolecular
respons
ligand
often
small
drug
molecul
neurotransmitt
hormon
lymphokin
lectin
antigen
could
also
anoth
biopolym
macromolecul
case
dock
dock
dock
molecular
model
techniqu
design
find
proper
fit
ligand
bind
site
receptor
dock
pose
ligand
molecul
bind
receptor
multipl
posit
conform
orient
dock
mode
call
dock
pose
bind
mode
bind
mode
orient
ligand
rel
receptor
well
conform
ligand
receptor
bound
dock
score
process
evalu
particular
pose
count
number
favor
intermolecular
interact
hydrogen
bond
hydrophob
contact
order
recogn
energet
favor
pose
pose
evalu
base
compat
target
term
shape
properti
electrostat
gener
correspond
dock
score
good
dock
score
given
ligand
signifi
potenti
good
binder
rank
rank
process
classifi
ligand
like
interact
favor
particular
receptor
base
predict
free
energi
bind
complet
dock
ligand
consequ
rank
respect
dock
score
ie
predict
affin
rankord
list
employ
synthesi
biolog
investig
compound
predict
activ
pose
predict
pose
predict
defin
search
accur
bind
mode
ligand
typic
carri
perform
number
trial
keep
pose
energet
best
involv
find
correct
orient
correct
conform
dock
ligand
due
flexibl
natur
score
affin
predict
affin
predict
score
function
appli
energet
best
pose
n
number
best
pose
found
ligand
compar
affin
score
differ
ligand
give
rel
rank
order
score
function
gener
divid
two
main
group
one
main
group
compris
knowledgebas
score
function
deriv
use
statist
observ
interatom
contact
frequenc
distanc
larg
databas
crystal
structur
complex
group
contain
score
scheme
base
physic
interact
term
socal
energi
compon
method
base
assumpt
chang
free
energi
upon
bind
ligand
target
decompos
sum
individu
contribut
term
defin
main
energet
contribut
bind
event
follow
specif
interact
int
interact
ligand
receptor
solvent
solv
conform
chang
ligand
receptor
conf
motion
protein
ligand
complex
format
motion
receptor
crystal
structur
execut
dock
studi
essenti
receptor
structur
interest
structur
receptor
determin
experiment
techniqu
xray
crystallographi
nuclear
magnet
reson
nmr
easili
download
pdb
http
wwwrcsb
orgpdbhomehomedo
qualiti
receptor
structur
play
crucial
role
success
dock
studi
gener
higher
resolut
prefer
employ
crystal
structur
better
observ
dock
result
anoth
import
criterion
examin
qualiti
receptor
structur
factor
dwf
bfactor
temperatur
factor
use
describ
attenu
xray
scatter
coher
neutron
scatter
caus
thermal
motion
signifi
rel
vibrat
motion
differ
part
protein
atom
low
bfactor
belong
part
structur
well
order
atom
larg
bfactor
gener
belong
part
structur
flexibl
consequ
import
ensur
bfactor
atom
bind
site
region
logic
high
valu
impli
coordin
less
reliabl
identif
boundligand
cocryst
structur
knowledg
interact
correspond
protein
amino
acid
residu
import
start
dock
studi
receptor
homolog
model
thread
techniqu
contrari
xray
crystal
structur
protein
avail
one
opt
protein
structur
predict
techniqu
case
commonli
appli
techniqu
thread
homolog
model
case
thread
fold
recognit
techniqu
estim
made
whether
given
amino
acid
sequenc
compat
one
ligand
databas
hand
homolog
compar
model
reli
correl
homolog
sequenc
target
protein
least
one
known
structur
correct
homolog
model
gener
provid
sequenc
ident
given
target
sequenc
known
structur
templat
modest
homolog
model
build
effort
could
potenti
creat
receptor
structur
entir
target
famili
importantli
homolog
model
compar
econom
method
gener
divers
receptor
conform
use
either
singletempl
multipletempl
structur
enhanc
understand
select
structur
protein
interest
attain
either
experi
xray
crystal
structur
predict
receptor
homolog
model
dock
studi
perform
use
ligand
interest
employ
multipl
dock
techniqu
function
protein
unknown
may
vital
search
structur
hypothet
bind
site
bind
site
explor
bind
select
ligand
compar
known
bind
site
analysi
bind
site
characterist
interact
given
ligand
lead
import
insight
design
novel
ligand
dock
assum
ligand
molecul
discuss
earlier
section
dock
categor
three
main
class
dock
ii
acid
dock
iii
protein
dock
among
dock
common
research
area
import
structurebas
drug
design
ligand
dock
classifi
follow
manner
structur
use
relax
represent
molecular
surfac
method
allow
small
degre
overlap
ligand
protein
use
addit
energi
termsusu
interatom
van
der
waal
vdw
empir
score
function
advantag
soft
dock
comput
compet
easi
implement
import
rememb
soft
dock
account
minut
conform
chang
soft
dock
concept
propos
jiang
kim
describ
molecular
surfac
volum
cube
represent
cube
represent
impli
implicit
conform
chang
way
sizeshap
complementar
close
pack
import
liber
steric
overlap
allow
activ
site
sidechain
flexibl
anoth
way
provid
receptor
flexibl
backbon
kept
fix
sidechain
conform
sampl
method
origin
propos
leach
use
pregener
sidechain
rotam
librari
subsequ
subject
optim
ligand
dock
procedur
via
deadend
elimin
algorithm
optim
ligandsidechain
orient
score
order
rank
lowest
energi
combin
sidechain
ligand
conform
sinc
invent
approach
research
propos
mani
improv
techniqu
incorpor
continu
discret
sidechain
flexibl
ligand
dock
molecular
relax
method
account
protein
flexibl
first
use
rigidbodi
dock
place
ligand
bind
site
relax
protein
backbon
sidechain
atom
nearbi
initi
rigidbodi
dock
allow
atom
clash
protein
place
ligand
conform
order
consid
protein
conform
chang
thereaft
form
complex
relax
minim
mc
md
method
md
calcul
timedepend
behavior
molecular
system
provid
detail
inform
fluctuat
conform
chang
protein
nucleic
acid
method
regularli
use
examin
structur
dynam
thermodynam
biolog
molecul
complex
advantag
molecular
relax
method
addit
certain
backbon
flexibl
addit
sidechain
conform
chang
howev
compar
sidechain
flexibl
method
relax
method
demand
score
function
involv
sidechain
movement
also
challeng
task
backbon
sampl
one
signific
drawback
approach
time
consum
ensembl
dock
gain
consider
attent
method
incorpor
protein
flexibl
util
ensembl
protein
structur
repres
differ
possibl
conform
chang
commonli
full
receptor
ensembl
gener
md
mc
simul
homolog
model
approach
ensembl
gener
experiment
nmr
solut
structur
determin
multipl
xray
crystal
structur
strict
comparison
reveal
consider
overlap
dynam
inform
theoret
deriv
molecular
dynam
ensembl
experiment
deriv
nmr
ensembl
first
ensembl
studi
done
knegtel
et
al
averag
energi
grid
construct
combin
energi
grid
gener
experiment
determin
protein
structur
use
weight
scheme
follow
standard
ligand
dock
gener
ensembl
dock
algorithm
use
gener
new
protein
structur
instead
use
select
inducedfit
structur
given
protein
ensembl
ligand
sampl
one
basic
compon
dock
given
protein
target
sampl
algorithm
gener
possibl
ligand
orient
conform
pose
around
select
bind
site
protein
interest
point
bind
site
experiment
determin
activ
site
dimer
interfac
anoth
site
interest
without
doubt
ligand
sampl
flexibl
signific
area
dock
research
three
type
ligandsampl
algorithm
shape
match
systemat
search
stochast
algorithm
discuss
next
section
shape
match
approach
one
common
sampl
algorithm
employ
initi
stage
dock
earlier
step
advanc
ligand
sampl
method
ligand
place
use
criterion
molecular
surfac
place
ligand
must
harmon
molecular
surfac
bind
site
protein
gener
three
translat
three
rotat
degre
freedom
ligand
alloc
mani
possibl
ligandbind
orient
therefor
place
ligand
get
bound
protein
site
good
shape
complementar
major
goal
shape
match
algorithm
import
rememb
conform
ligand
normal
fix
shape
match
major
advantag
shape
match
comput
effici
systemat
search
algorithm
usual
employ
flexibl
ligand
dock
creat
probabl
ligand
bind
conform
explor
degre
freedom
ligand
systemat
search
method
divid
three
subclass
exhaust
search
uncompl
systemat
algorithm
exhaust
search
method
flexibl
ligand
dock
perform
systemat
rotat
possibl
rotat
bond
ligand
given
interv
spite
sampl
total
ligand
conform
number
choic
huge
due
increas
number
rotat
bond
consequ
make
dock
process
realist
geometr
chemic
constraint
normal
appli
initi
screen
ligand
pose
filter
ligand
conform
subject
precis
refin
optim
measur
b
fragment
approach
basic
idea
behind
approach
ligand
first
divid
number
fragment
ligandbind
conform
grown
place
one
fragment
time
bind
site
dock
fragment
bind
site
link
coval
c
conform
ensembl
conform
ensembl
method
ligand
flexibl
achiev
rigidli
dock
ensembl
pregener
ligand
conform
program
eg
omega
ligandbind
mode
differ
dock
run
collect
rank
accord
bind
energi
score
fundament
algorithm
behind
stochast
approach
ligandbind
orient
conform
sampl
make
random
chang
ligand
step
conform
space
translat
rotat
space
ligand
respect
random
chang
accept
reject
accord
probabilist
criterion
stochast
algorithm
classifi
four
differ
categori
mc
method
probabl
allow
random
chang
determin
employ
boltzmann
probabl
function
b
evolutionari
algorithm
involv
search
right
ligandbind
mode
base
idea
evolutionari
process
biolog
system
c
tabu
search
method
probabl
approv
reli
explor
area
conform
space
ligand
random
chang
reject
rmsd
present
ligandbind
conform
formerli
record
solut
less
cutoff
otherwis
random
chang
accept
swarm
optim
method
particular
algorithm
tri
determin
best
possibl
solut
search
space
model
swarm
intellig
movement
ligand
mode
search
space
direct
inform
best
posit
neighbor
fundament
element
behind
determin
accuraci
dock
algorithm
gener
score
function
dock
studi
swift
precis
two
essenti
aspect
score
function
ideal
score
function
would
comput
profici
consist
numer
score
function
develop
sinc
introduct
dock
studi
score
function
broadli
group
five
basic
categori
accord
method
deriv
ff
score
function
reli
partit
ligandbind
energi
individu
interact
term
vdw
energi
electrostat
energi
bond
stretchingbendingtorsion
energi
employ
set
deriv
ff
paramet
amber
charmm
ff
major
challeng
ff
score
function
account
solvent
effect
account
entrop
effect
bind
energi
score
complex
calcul
ad
set
weight
empir
energi
term
vdw
energi
electrostat
energi
hydrogenbond
energi
desolv
term
entropi
term
hydrophob
term
empir
score
function
compar
ff
score
function
empir
score
function
usual
much
comput
profici
due
simpl
energi
term
interest
point
gener
applic
empir
score
function
reli
train
set
due
fact
fit
known
bind
affin
train
set
knowledgebas
score
function
result
structur
inform
experiment
determin
complex
theori
beneath
knowledgebas
score
function
potenti
mean
forc
defin
invers
boltzmann
relat
score
function
maintain
good
balanc
accuraci
speed
difficulti
score
function
calcul
aforement
refer
state
classifi
three
categori
base
method
comput
tradit
atomrandom
refer
state
b
correct
refer
state
c
circumv
refer
state
consensu
score
typic
score
function
rather
techniqu
involv
dock
advanc
probabl
find
accur
solut
amalgam
score
inform
multipl
score
function
anticip
elimin
inaccuraci
individu
score
function
consequ
main
difficulti
consensu
score
creat
combin
rule
score
true
binder
discrimin
other
accord
consensu
rule
enhanc
perform
score
function
anoth
new
techniqu
call
clusteringbas
score
method
includ
entrop
effect
divid
gener
ligandbind
mode
differ
cluster
entrop
contribut
cluster
calcul
configur
space
cover
ligand
pose
number
ligand
pose
cluster
one
disadvantag
clusteringbas
score
method
perform
reli
ligand
sampl
protocol
highli
depend
dock
program
fundament
dock
threestep
process
irrespect
softwar
dock
algorithm
step
follow
ligand
prepar
first
step
prepar
ligand
process
duplic
structur
remov
option
ioniz
chang
tautom
isom
gener
gener
must
set
work
softwar
platform
respect
ligand
b
protein
prepar
hydrogen
atom
ad
protein
must
minim
use
softwarespecif
ff
follow
remov
water
molecul
except
activ
site
protein
adjust
fix
seriou
error
like
incomplet
residu
near
activ
site
charg
atom
type
metal
atom
set
properli
need
bond
metal
ion
bond
delet
follow
adjust
formal
charg
atom
attach
metal
well
metal
protein
molecul
thu
prepar
total
receptor
readi
dock
c
dock
ensur
protein
ligand
correct
form
dock
case
receptor
grid
file
gener
use
receptor
gener
program
gridbas
dock
grid
box
gener
gener
centroid
ligand
bound
activ
site
receptor
case
activ
pocket
protein
identifi
dock
prepar
ligand
identifi
pocket
initi
molecul
data
set
dock
activ
site
protein
interact
energi
ligand
receptor
calcul
obtain
result
need
compar
bound
ligand
crystal
protein
structur
order
assess
whether
molecul
fit
specifi
activ
site
receptor
set
number
ligand
pose
save
conform
ligand
predefin
number
dock
pose
thu
save
conform
compound
rank
accord
dock
score
function
interact
receptor
analyz
dock
studi
interact
correl
biolog
activ
data
set
compound
structur
valid
dock
procedur
done
extract
cocrystal
ligand
activ
site
receptor
redock
receptor
ensur
bind
activ
site
interact
amino
acid
residu
basic
step
schemat
illustr
figur
signific
amount
work
perform
devis
superior
dock
program
score
function
past
year
howev
still
room
improv
section
present
primari
challeng
requir
improv
advanc
perform
dock
score
challeng
water
molecul
protein
water
molecul
often
play
signific
role
interact
watermedi
interact
dock
ignor
estim
interact
energi
given
ligand
conform
may
low
contrari
one
hold
water
molecul
present
crystal
protein
structur
bind
pose
affin
ligand
reliabl
thu
difficult
treat
water
molecul
effect
perform
reliabl
accept
dock
one
first
need
recogn
probabl
posit
water
molecul
could
interact
protein
ligand
subsequ
one
must
capabl
predict
whether
water
molecul
inde
present
posit
b
tautom
protom
anoth
signific
challeng
dock
consider
variou
tautomer
protomer
state
molecul
adopt
time
molecul
acid
amin
store
neutral
form
ioniz
physiolog
condit
essenti
ioniz
prior
dock
although
ioniz
easi
attain
problem
tautom
gener
alreadi
much
difficult
question
aris
tautom
one
use
one
use
one
possibl
tautom
given
molecul
tautom
also
differ
ioniz
state
ligand
provid
real
challeng
dock
applic
masc
simpl
statist
correct
score
function
prefer
certain
ligand
type
characterist
larg
hydrophob
ligand
consequ
ligand
predict
good
binder
regardless
whether
ligand
bind
specif
activ
site
therefor
masc
introduc
interpret
either
statist
measur
ligand
specif
correct
ligandrel
bia
score
function
order
calcul
masc
score
ligand
dock
number
unrel
bind
site
differ
bind
site
characterist
correct
score
masc
score
ij
ligand
molecul
bind
site
j
calcul
follow
ij
uncorrect
score
ligand
repres
mean
standard
deviat
score
ligand
molecul
across
differ
bind
site
thu
masc
score
ij
repres
measur
specif
molecul
bind
site
j
compar
bind
site
e
dock
constraint
introduc
constraint
dock
feasibl
control
way
pose
gener
one
preferenti
set
asid
exampl
case
dockit
program
one
appli
distanc
constraint
ligand
protein
consequ
util
pose
gener
via
distanc
geometri
approach
f
postprocess
two
approach
postprocess
employ
case
dock
studi
appli
postdock
filter
ii
use
tailormad
rescor
function
postdock
filter
theoret
simpl
may
correspond
certain
geometr
criteria
like
exist
certain
interact
eg
hydrogen
bond
select
residu
polar
interact
fill
specifi
pocket
activ
site
score
function
may
exhibit
bias
behavior
certain
compound
class
function
group
diminish
impact
difficulti
decreas
statist
nois
composit
score
rescor
method
introduc
rather
use
singl
score
function
sever
score
function
merg
order
classifi
potenti
binder
molecul
score
well
number
differ
score
function
anoth
way
postprocess
use
dock
result
input
develop
bayesian
model
aim
reduc
number
fals
posit
fals
neg
dock
technolog
success
appli
multipl
stage
drug
design
discoveri
process
three
main
purpos
predict
bind
mode
known
activ
ligand
identifi
new
ligand
use
vs
predict
bind
affin
alli
compound
known
activ
seri
predict
ligandbind
mode
protein
activ
site
success
area
broader
perspect
major
specif
applic
dock
list
get
proper
dimens
use
dock
studi
drug
discoveri
process
determin
lowest
freeenergi
structur
complex
calcul
differenti
bind
ligand
two
differ
macromolecular
receptor
studi
geometri
particular
complex
search
databas
rank
hit
lead
gener
optim
futur
drug
candid
propos
modif
lead
molecul
optim
potenc
properti
librari
design
data
bank
gener
screen
side
effect
caus
interact
protein
like
proteas
cytochrom
done
also
possibl
check
specif
potenti
drug
homolog
protein
dock
dock
also
wide
use
tool
predict
interact
dock
creat
knowledg
molecular
associ
aid
understand
varieti
pathway
take
place
live
system
reveal
possibl
potenti
pharmacolog
target
dockingbas
virtual
ht
less
expens
normal
ht
faster
convent
screen
dock
studi
huge
role
lead
drug
identif
process
also
search
potenti
target
identif
differ
diseas
repres
list
market
clinic
trial
drug
employ
structurebas
drug
studi
given
tabl
elabor
illustr
pleas
see
chapter
larg
number
dock
program
search
algorithm
report
sinc
invent
dock
although
basic
step
dock
process
less
ident
dock
program
vari
fundament
respect
dock
algorithm
ligand
search
strategi
score
function
techniqu
list
popular
dock
softwar
program
given
tabl
hint
softwar
packag
util
experiment
solvent
partit
data
basi
empir
molecular
interact
model
program
calcul
empir
atombas
hydropath
paramet
sens
encod
signific
intermolecular
intramolecular
noncoval
interact
implic
drug
bind
protein
fold
liaison
liaison
commerci
program
fast
estim
free
energi
bind
receptor
ligand
free
energi
bind
approxim
equat
free
bound
state
ligand
calcul
method
combin
highlevel
molecular
mechan
calcul
experiment
data
build
score
function
evalu
bind
free
energi
ligandfit
shape
match
moment
inertia
algorithm
employ
continu
recent
year
increas
attent
paid
develop
new
method
employ
combin
inform
gener
receptor
ligand
common
presentday
potenti
futur
approach
discuss
section
concept
compar
bind
energi
compar
bind
energi
combin
analysi
method
develop
systemspecif
express
comput
bind
free
energi
use
structur
complex
techniqu
base
upon
hypothesi
free
energi
bind
correl
subset
energi
compon
molegro
virtual
docker
integr
platform
predict
interact
molegro
virtual
docker
handl
aspect
dock
process
prepar
molecul
determin
potenti
bind
site
target
protein
predict
bind
mode
ligand
qsite
qsite
mixedmod
qmmm
program
highli
accur
energi
calcul
interact
activ
site
program
specif
design
protein
allow
number
differ
qmmm
boundari
residu
activ
site
qsite
use
power
speed
jaguar
perform
quantum
mechan
part
calcul
oplsaa
perform
molecular
mechan
part
calcul
situ
program
packag
dock
protein
crystal
structur
singlemolecul
lowresolut
map
electron
microscopi
smallangl
xray
scatter
slide
descriptor
match
algorithm
employ
slide
superstar
program
gener
map
interact
site
protein
use
experiment
inform
intermolecular
interact
gener
interact
map
therefor
fulli
knowledgebas
superstar
retriev
data
isostar
ccdc
interact
databas
isostar
contain
inform
nonbond
interact
cambridg
structur
databas
csd
protein
data
bank
pdb
calcul
structur
receptor
ligand
bound
unbound
form
comput
bind
free
energi
challeng
due
need
sampl
conform
space
effect
order
comput
entrop
contribut
empir
score
function
fast
calcul
deriv
approxim
bind
free
energi
use
singl
structur
complex
experiment
bind
data
access
set
relat
complex
inform
use
deriv
targetspecif
score
function
algorithm
taken
combin
analysi
bind
free
energi
inhibit
constant
k
relat
properti
correl
subset
weight
interact
energi
compon
determin
structur
energi
minim
complex
receptor
bind
free
energi
ligand
express
n
term
rep
bind
energi
select
coeffici
constant
c
determin
statist
analysi
calcul
repres
conform
complex
unbound
ligand
receptor
use
molecular
mechan
ff
ligand
divid
n
l
fragment
receptor
n
r
region
eg
amino
acid
residu
thu
first
two
term
right
side
equat
describ
intermolecular
interact
energi
fragment
ligand
region
j
receptor
next
four
term
describ
chang
bond
bond
angl
torsion
nonbond
combin
electrostat
energi
ligand
fragment
upon
bind
receptor
last
four
term
account
chang
bond
nonbond
energi
receptor
region
upon
bind
ligand
deriv
combin
model
fundament
three
step
follow
name
model
molecul
complex
measur
interact
energi
ligand
receptor
final
perform
chemometr
analysi
deriv
regress
equat
methodolog
combin
analysi
outlin
schemat
figur
molecular
model
develop
combin
model
ligand
divid
fragment
number
fragment
must
alloc
compound
ad
dummi
fragment
ligand
lack
correct
number
model
complex
unbound
receptor
ligand
deriv
standard
molecular
mechan
program
differ
regress
equat
produc
use
follow
factor
differ
start
conform
receptor
inclus
posit
restraint
part
receptor
differ
converg
criteria
energi
minim
differ
way
treat
interfac
dielectr
environ
b
measur
interact
energi
object
step
comput
nonbond
vdw
electrostat
interact
energi
residu
receptor
everi
fragment
ligand
use
molecular
mechan
ff
along
interact
energi
energi
pair
residu
fragment
complex
free
ligand
receptor
basi
distancebas
dielectr
constant
comput
well
final
matrix
form
column
repres
energi
compon
row
repres
compound
set
final
column
contain
experiment
activ
inhibitori
activ
bind
affin
ad
matrix
depend
variabl
model
develop
c
chemometr
analysi
complet
step
signific
descriptor
retain
other
must
elimin
studi
matrix
due
larg
number
variabl
intercorrel
natur
partial
least
squar
pl
techniqu
choic
deriv
qsar
model
quantifi
import
energi
interact
term
activ
predict
compar
combin
method
calcul
bind
energi
via
classic
molecular
mechan
advantag
interact
energi
statist
analysi
follow
nois
due
inaccuraci
potenti
energi
function
molecular
model
reduc
b
mechanist
import
interact
term
identifi
c
compar
tradit
qsar
analysi
approach
anticip
predict
incorpor
physic
relev
inform
energi
interact
help
screen
lead
compound
base
requir
properti
interact
favor
key
residu
combin
experi
intrins
error
implic
comput
interact
energi
ligand
macromolecular
complex
like
interact
energybas
method
predict
method
improv
make
advanc
sever
aspect
like
descript
electrostat
term
addit
appropri
descriptor
solvat
entrop
effect
optim
methodolog
choic
ligand
fragment
definit
detail
variabl
select
protocol
combin
analysi
origin
develop
studi
interact
one
target
protein
set
relat
ligand
establish
recent
time
approach
appli
tact
wide
rang
complex
includ
substrat
inhibitor
complex
complex
complex
also
employ
examin
bind
one
target
protein
receptor
make
combin
method
user
friendli
method
implement
structurebas
compound
optim
priorit
evolut
scope
modul
vlifemd
use
approach
deriv
experiment
biolog
activ
calcul
ligand
interact
energi
term
first
execut
combin
analysi
ligand
particular
target
dock
target
requir
train
set
dock
optim
complex
unbound
ligand
receptor
intermolecular
intramolecular
interact
energi
calcul
calcul
descriptor
correl
experiment
activ
studi
compound
develop
qsar
model
final
interpret
develop
mathemat
equat
enlighten
import
interact
futur
drug
design
develop
process
gcombin
gcombin
userfriendli
tool
perform
combin
analysi
drug
design
research
program
graphic
user
interfac
gui
written
java
purpos
perform
combin
analysi
set
complex
intent
deriv
highli
inform
qsar
model
object
method
gener
interact
energi
seri
variabl
explor
origin
varianc
within
set
employ
princip
compon
analysi
pca
alloc
weight
chosen
interact
use
pl
analysi
correl
experiment
activ
bind
affin
major
advantag
use
gui
allow
plenti
interact
provid
multipl
plot
repres
energi
descriptor
enter
analysi
score
load
experiment
versu
predict
regress
line
evolut
classic
valid
paramet
use
gui
one
carri
numer
ad
task
possibl
truncat
posit
interact
energi
valu
gener
readymad
pdb
file
contain
inform
relat
import
activ
individu
protein
residu
inform
aptli
display
colorcod
use
molecular
graphic
program
like
pymol
coria
analysi
rel
recent
innov
field
qsar
studi
approach
use
descriptor
describ
thermodynam
event
involv
ligand
bind
receptor
explor
qualit
quantit
facet
recognit
process
main
emphasi
coria
calcul
analyz
complex
thereaft
predict
bind
affin
complex
bind
freeenergi
differ
bind
free
bound
state
receptor
ligand
complex
uncomplex
relat
bind
constant
k
ligand
receptor
express
addit
interact
differ
event
use
classic
bind
free
energi
equat
total
free
energi
bind
bind
addit
interact
solvat
ligand
solv
differ
unbound
eg
cellular
bound
state
conform
chang
occur
receptor
ligand
conf
specif
interact
ligand
receptor
consequ
proxim
inter
motion
receptor
ligand
close
motion
first
step
coria
calcul
bind
energi
form
nonbond
interact
energi
like
vdw
coulomb
describ
thermodynam
event
involv
ligand
bind
activ
site
receptor
thereaft
employ
genet
version
pl
techniqu
name
gpl
calcul
energi
correl
biolog
activ
molecul
along
physiochem
variabl
like
molar
refract
surfac
area
molecular
volum
jur
descriptor
strain
energi
valid
perform
develop
coria
model
base
variou
valid
metric
ensur
accept
develop
model
methodolog
coria
schemat
present
figur
recent
year
deal
problem
peptid
qsar
coria
methodolog
gone
sever
advanc
modif
two
newli
develop
variant
coria
reversecoria
rcoria
peptid
ligand
fragment
individu
amino
acid
interact
energi
vdw
coulomb
hydrophob
interact
amino
acid
peptid
total
receptor
calcul
techniqu
known
rcoria
b
mixedcoria
mcoria
interact
energi
amino
acid
peptid
individu
activ
site
residu
receptor
calcul
approach
defin
mcoria
approach
along
interact
energi
thermodynam
descriptor
like
free
energi
solvat
entropi
loss
bind
strain
energi
solvent
assess
surfac
area
also
includ
independ
variabl
correl
biolog
activ
use
gpl
techniqu
like
gener
coria
signific
import
coria
methodolog
capabl
extract
critic
inform
regard
natur
type
import
interact
level
receptor
ligand
gener
rich
sourc
inform
directli
employ
design
new
molecul
drug
target
approach
abil
forecast
modif
ligand
receptor
provid
structur
complex
avail
coria
approach
use
identifi
crucial
interact
inhibitor
enzym
residu
level
profit
exploit
optim
inhibitori
activ
ligand
furthermor
use
guid
point
mutat
studiesyet
anoth
advantag
major
drawback
coria
appli
small
organ
molecul
unlik
peptid
ration
unanim
establish
protocol
fragment
small
molecul
vs
techniqu
identifi
novel
hit
ie
bioactiv
molecul
larg
chemic
librari
comput
mean
appli
knowledg
protein
target
structurebas
vs
known
bioactiv
ligand
ligandbas
vs
ligandbas
approach
util
data
set
known
activ
order
identifi
drug
candid
experiment
evalu
ligandbas
method
includ
approach
like
similar
substructur
search
qsar
pharmacophorebas
search
shape
match
appar
structurebas
vs
mainli
employ
dock
approach
structur
biolog
target
protein
receptor
use
dock
candid
molecul
rank
base
predict
bind
affin
dock
score
techniqu
like
epharmacophor
fingerprint
also
use
structurebas
vs
import
mention
base
requir
research
one
use
ligandand
structurebas
approach
one
one
layer
screen
techniqu
approach
concurr
vs
technolog
emerg
respons
pressur
combinatori
ht
commun
vs
consid
mine
chemic
space
aim
identifi
molecul
possess
desir
properti
vs
approach
highli
depend
quantiti
qualiti
avail
data
predict
underli
algorithm
consequ
univers
guidelin
workflow
vs
approach
research
appli
comput
knowledg
experi
find
activ
drug
candid
sea
drug
databas
chemic
librari
appli
best
possibl
sourc
tool
per
requir
experiment
effort
carri
biolog
screen
billion
compound
still
consider
high
therefor
cadd
approach
becom
attract
altern
one
rememb
workflow
employ
vs
univers
workflow
sole
depend
research
need
divers
chemic
librari
avail
sourc
sensibl
practic
vs
tri
describ
gener
commonli
employ
workflow
first
criterion
vs
approach
select
requir
chemic
librari
take
requir
consider
research
select
chemic
librari
avail
larg
pool
public
commerci
databas
databas
may
cover
particular
class
compound
structur
pharmacolog
divers
class
molecul
signific
amount
inform
regard
variou
type
chemic
librari
provid
section
select
requir
databas
one
perform
preprocess
chemic
librari
remov
duplic
structur
tautom
counter
ion
proton
one
next
step
filter
druglik
molecul
preprocess
chemic
librari
differ
druglik
filter
need
employ
lipinski
rule
five
wellknown
rule
thumb
encod
simpl
profil
permeabl
oral
avail
drug
filter
demonstr
poor
absorpt
permeat
like
occur
molecular
weight
mw
ii
calcul
octanolwat
partit
coeffici
logp
iii
presenc
hbd
iv
presenc
hba
except
logp
criteria
addit
accur
comput
screen
virtual
librari
howev
lipinski
rule
five
fail
distinguish
drug
nondrug
rather
serv
method
predict
compound
poor
absorpt
permeabl
one
rememb
antibiot
fall
outsid
scope
rule
b
admet
filter
addit
lipinski
filter
admet
filter
employ
filter
get
earli
inform
regard
absorpt
distribut
metabol
excret
adm
toxic
data
admet
data
admet
filter
screen
use
late
stage
failur
molecul
clinic
trial
primarili
attribut
inabl
meet
necessari
pharmacokinet
profil
accur
predict
admet
properti
enabl
elimin
unwant
molecul
aid
lead
optim
process
ultim
screen
step
vs
filter
druglik
compound
base
two
fundament
approach
name
ligandbas
approach
receptorbas
approach
ligandbas
approach
approach
molecul
physic
chemic
properti
similar
known
ligand
identifi
use
qsar
model
pharmacophorebas
search
substructur
search
atom
propertybas
search
approach
ligandbas
approach
possibl
without
protein
inform
employ
scaffold
hop
sinc
techniqu
bias
properti
known
ligand
limit
divers
hit
gener
b
receptorbas
approach
approach
use
techniqu
like
dock
differ
score
function
activesitedirect
sbp
molecular
recognit
ligand
target
protein
select
chemic
entiti
bind
activ
site
biolog
relev
target
known
structur
major
advantag
approach
follow
possibl
carri
process
without
ligand
inform
entir
capabl
protein
pocket
taken
account
predict
bind
mode
possibl
scaffold
hop
profil
without
bia
toward
exist
ligand
done
c
combin
ligandand
receptorbas
approach
univers
method
vs
one
use
ligandand
structurebas
method
separ
eg
pharmacophor
dock
one
one
twolay
techniqu
employ
combin
ligandand
structurebas
method
like
combin
coria
combin
coria
approach
reliabl
consid
ligand
receptor
inform
well
inform
regard
bind
complex
machin
learn
techniqu
apart
ligandand
receptorbas
approach
machin
learn
techniqu
like
support
vector
machin
svm
binari
kernel
discrimin
bkd
tact
appli
case
vs
svm
predict
bioactiv
repres
lead
ndimension
real
space
use
molecular
descriptor
fingerprint
technolog
n
repres
number
featur
attribut
svm
approach
base
fuzzi
logic
fingerprint
bkd
recent
develop
comput
approach
bkd
molecul
repres
fragment
bitstr
consist
three
compon
first
structur
represent
section
second
similar
search
section
use
differ
coeffici
third
section
differ
weight
scheme
lead
compound
hit
select
final
screen
process
one
synthes
purchas
hit
studi
select
hit
go
differ
vitroin
vivo
bioassay
final
confirm
pharmacolog
action
compound
show
encourag
pharmacolog
activ
consid
lead
one
preclin
clinic
studi
establish
final
drug
candid
schemat
illustr
variou
step
vs
present
figur
employ
vs
approach
mani
drug
obtain
alreadi
market
other
differ
stage
clinic
trial
liebeschuetz
et
al
use
librari
designand
structurebas
vs
develop
inhibitor
factor
xa
serin
proteas
import
target
blood
coagul
cascad
sharma
et
al
carri
vs
find
neuraminidas
inhibitor
potenti
target
swine
flu
two
metabolit
hesperidin
narirutin
predict
potent
exist
drug
oseltamivir
dahlgren
et
al
develop
salicyliden
acylhydrazid
inhibitor
type
iii
secret
gramneg
pathogen
yersinia
pseudotuberculosi
set
virtual
compound
employ
three
qsar
model
studi
numer
made
repres
list
success
applic
vsbase
drug
discoveri
tabl
applic
vs
techniqu
increas
chanc
success
drug
discoveri
mani
time
without
hesit
say
vs
emerg
reliabl
costeffect
timesav
techniqu
discoveri
lead
compound
main
advantag
method
compar
laboratori
experi
describ
next
section
compound
purchas
extern
synthes
chemist
initi
stage
vs
one
cost
effect
drug
discoveri
process
synthesi
take
extrem
long
time
especi
case
larg
databas
million
chemic
compound
employ
comput
tool
vs
approach
alway
effici
drug
discoveri
synthesi
bioassay
alway
involv
great
amount
human
strength
chanc
get
fals
posit
alway
present
even
spend
lot
physic
mental
labor
although
undeni
vs
also
chanc
result
fals
posit
alway
laboreffici
drug
develop
possibl
investig
compound
synthes
yet
conduct
ht
experi
costli
timeconsum
labori
larg
number
chemic
result
vs
alway
ration
option
minim
initi
number
compound
use
ht
method
appli
vs
techniqu
research
must
face
mani
difficulti
find
best
possibl
balanc
effici
precis
evalu
particular
algorithm
determin
method
achiev
better
result
situat
defin
whether
univers
method
workflow
vs
consid
altitud
set
paramet
data
set
research
explor
larg
number
if
but
execut
vs
mani
known
limit
well
stillunreport
one
vs
techniqu
probabl
pitfal
discuss
follow
section
along
possibl
way
resolv
pitfal
classifi
four
categori
erron
assumpt
expect
b
data
design
content
c
choic
softwar
conform
sampl
well
ligand
target
flexibl
schemat
represent
shown
figur
predict
wrong
bind
pose
case
even
though
predict
dock
bind
pose
wrong
dock
screen
accident
gener
high
score
mani
hit
watermedi
bind
interact
mani
dock
studi
hydrogen
bond
ligand
protein
form
water
often
visibl
crystal
structur
complex
watermedi
hydrogen
bond
taken
account
structurebas
vs
studi
difficult
predict
exact
number
posit
orient
interact
singleversu
allostericbind
pocket
structureand
ligandbas
vs
approach
intrins
limit
incap
identifi
bioactiv
ligand
bind
pocket
explicitli
dock
implicitli
repres
train
set
unknown
bind
site
ligand
complic
problem
properli
assess
hit
rate
vs
experi
prospect
valid
vs
habitu
perform
data
set
known
activ
often
put
inact
molecul
result
mani
case
good
number
inact
molecul
absent
identifi
true
inact
vs
approach
druglik
major
vs
approach
base
screen
druglik
compound
employ
lipinski
rule
five
preliminari
screen
step
vs
one
rememb
rule
appli
oral
bioavail
mani
bioactiv
class
antibiot
fall
outsid
scope
rule
henc
vs
protocol
gener
appli
valid
rel
small
fraction
chemic
space
perform
may
chang
drastic
one
databas
anoth
b
data
design
content
size
divers
chemic
librari
mani
case
employ
librari
vs
either
small
contain
mani
close
relat
analog
often
data
set
lack
suffici
chemic
divers
never
ideal
choic
vs
experiment
error
inappropri
bioassay
larg
pool
data
set
often
assembl
differ
sourc
differ
bioassay
procedur
detect
techniqu
use
consequ
huge
risk
experiment
error
inappropri
assay
molecul
molecul
bad
reactiveaggreg
molecul
data
set
provid
vs
often
includ
molecul
contain
chemic
reactiv
group
undesir
function
may
interfer
ht
detect
techniqu
put
inact
compound
decoy
experiment
confirm
inact
compound
help
neg
control
appear
hit
list
reliabl
vs
protocol
employ
howev
mani
decoy
use
vs
benchmark
studi
put
inact
henc
assum
true
neg
may
actual
posit
c
choic
softwar
molecul
drawingprepar
ad
implicit
hydrogen
atom
handl
ioniz
state
molecul
assign
correct
charg
initi
stage
vs
screen
easili
forgotten
mani
case
final
result
total
mislead
scientif
commun
inputoutput
error
format
incompat
variou
error
introduc
interconvert
differ
molecular
format
one
softwar
anoth
high
possibl
get
distort
inform
like
chang
atom
coordin
chiral
hybrid
proton
state
employ
compound
improp
featur
definit
pharmacophor
incorrect
featur
definit
detriment
outcom
vs
pharmacophor
queri
definit
pharmacophor
featur
need
appli
caution
exampl
known
nitrogen
oxygen
atom
heterocycl
oxazol
behav
hba
simultan
major
case
acceptor
oxazol
ring
nitrogen
dispar
algorithm
softwar
softwar
variou
softwar
tool
appli
differ
algorithm
particular
job
exampl
case
dock
energi
minim
differ
form
ff
appli
one
softwar
anoth
therefor
high
probabl
get
differ
hit
make
vs
process
highli
depend
use
particular
softwar
singl
predictor
versu
ensembl
multipl
statist
tool
free
commerci
softwar
descriptor
avail
perform
vs
studi
modul
captur
differ
characterist
molecular
similar
consequ
alway
difficult
identifi
prefer
toolsoftwaredescriptor
therefor
often
necessari
account
sever
approach
rather
one
conform
sampl
well
ligand
target
flexibl
conform
coverag
one
main
challeng
gener
conveni
set
conform
cover
molecul
conform
space
effect
highenergi
conform
one
rememb
good
conform
coverag
import
contrari
highenergi
physic
unrealist
conform
detriment
vs
conform
sampl
approach
util
energi
minim
refin
properli
rank
result
geometri
therefor
result
list
could
contain
mani
fals
posit
ligand
protein
flexibl
common
practic
mani
databas
search
system
set
limit
number
conform
store
molecul
number
conform
access
molecul
depend
greatli
size
flexibl
cours
ligand
flexibl
biolog
target
well
protein
flexibl
probabl
unexploit
aspect
vs
assumpt
ligand
overlap
shapebas
vs
program
attempt
maxim
overlap
queri
databas
molecul
inde
differ
ligand
may
occupi
differ
region
protein
even
bind
site
overlap
space
much
less
assum
shapebas
vs
tool
result
fals
neg
chemic
divers
librari
particularli
attract
identifi
novel
scaffold
new
rel
unexplor
target
result
diversityori
synthesi
one
need
rememb
databas
librari
must
fit
purpos
experi
select
screen
larg
number
databas
publicli
avail
number
increas
day
day
recent
initi
requir
greater
use
silico
technolog
call
transpar
develop
strong
databas
inform
avail
public
cost
electron
inform
chemic
structur
pharmacolog
activ
specif
known
molecular
target
serv
wide
varieti
purpos
field
vs
tabl
summar
list
current
public
commerci
chemic
databas
commonli
screen
practic
scientif
commun
take
initi
develop
databas
public
administr
use
near
futur
lbp
approach
structurebas
molecular
dock
play
promis
role
identif
optim
lead
modern
drug
discoveri
pharmacophor
dockingbas
approach
employ
alon
concurr
vs
lead
much
higher
hit
rate
tradit
screen
method
eg
ht
complet
structur
divers
data
set
pharmacophor
give
immens
confid
best
probabl
featur
sole
respons
particular
pharmacolog
activ
contrari
dock
method
provid
opportun
design
activ
compound
consid
bind
aspect
ligand
amino
acid
residu
respect
receptor
method
like
coria
combin
provid
blend
ligandand
structurebas
drug
design
best
possibl
interact
complex
identifi
method
capabl
extract
critic
inform
regard
natur
type
import
interact
level
receptor
ligand
vs
approach
vigor
implement
pharmaceut
industri
intent
obtain
mani
potenti
compound
possibl
hope
greater
chanc
find
hit
avail
larg
pool
chemic
librari
mani
success
exampl
demonstr
recent
field
computeraid
vs
lead
identif
appear
univers
method
execut
studi
biolog
target
system
uniqu
although
one
ignor
intrins
restrict
vs
remain
one
best
possibl
option
explor
larg
chemic
space
term
cost
effect
commit
time
materi
need
develop
new
dock
methodolog
ligandbas
screen
techniqu
machinelearn
tool
vs
techniqu
capabl
give
better
hit
predict
rate
undoubtedli
play
frontrunn
role
drug
design
near
futur
either
complementari
approach
ht
standalon
approach
one
rememb
technolog
avail
need
employ
right
way
right
direct
identifi
novel
chemic
substanc
scientif
use
vs
techniqu
howev
must
emphas
vs
intend
replac
actual
experiment
approach
matter
fact
vs
experiment
method
highli
complementari
